A food-effect study of RHB-105 in healthy volunteers.
Latest Information Update: 04 Aug 2023
At a glance
- Drugs Amoxicillin/omeprazole/rifabutin (Primary)
- Indications Helicobacter pylori infections
- Focus Pharmacokinetics; Registrational
- Sponsors RedHill Biopharma
- 01 Aug 2023 According to a RedHill Biopharma media release, Gaelan Medical received marketing approval from the United Arab Emirates (UAE) Ministry of Health for Talicia (omeprazole magnesium, amoxicillin and rifabutin).
- 04 Nov 2019 According to an RedHill Biopharma media release, the company will host an Investor and Analyst day on November 22, 2019 in New York to review launch plans for Talicia and provide an overview of the Company's commercial operations.
- 04 Nov 2019 According to an RedHill Biopharma media release, the company announced that the U.S. Food and Drug Administration (FDA) has approved Talicia(omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules 10 mg1/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori) infection in adults.